Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Biotechnology

Health Care

Life Sciences

Therapeutics

Crossbow Therapeutics, Inc

Briggs Morrison

Vinutha Chandrababu

Tao Wang

Bhupal Ban

Benjamin Lee

Amanda Mak

Dmitri Wiederschain

The Scientific Research and Development team at Crossbow Therapeutics, Inc., spearheads the discovery, engineering, and development of T-Bolt™ therapies. They focus on advancing T-cell receptor-mimetic antibodies to precisely target and treat various cancers. This team plays a critical role in the innovation and optimization of immunotherapies, ensuring they are effective and scalable for clinical use.

Scientific Research and Development

Leadership Team

Scientific Research and Development

About

Team members

Other teams at Crossbow Therapeutics, Inc

Leadership Team